Tag: Quantum BioPharma Ltd.

Client News & Interviews

March 27, 2025 • Views: 10

Canadian Biotech Quantum BioPharma Nears a Landmark Multiple Sclerosis Breakthrough

Client News & Interviews

March 25, 2025 • Views: 5

Canadian Small Cap Quantum BioPharma on The Verge of Multiple Sclerosis Breakthrough

Client News & Interviews

March 24, 2025 • Views: 9

Quantum BioPharma Successfully Completes First Human Trial for New Multiple Sclerosis Drug 

Sector Insights

February 27, 2025 • Views: 5

Quantum BioPharma Targets $40B MS Market with Lucid-MS Following Successful Phase 1 Trial – Poised for $1B+ Potential

Client News & Interviews

November 19, 2024 • Views: 16

Quantum BioPharma (Formerly FSD Pharma) Sues CIBC, RBC & Others For $700 Million Alleging Spoofing/Short Selling Stock Manipulation

Client News & Interviews

November 18, 2024 • Views: 24

Quantum BioPharma Sues CIBC, RBC & Others For $700 Million Alleging Spoofing/Short Selling Stock Manipulation

Client News & Interviews

October 21, 2024 • Views: 5

Quantum BioPharma Files $700 Million USD Lawsuit Against CIBC, RBC, and Others for Alleged Stock Manipulation

↑